What question did this study set out to answer?

This research investigates the role of tumor-specific CD4(+) T cells in improving CD8(+) T cell adoptive immunotherapy effectiveness.

Tumor‐specific CD4+T cells maintain effector and memory tumor‐specific CD8+T cells

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial examines CD4+ T cells' role in boosting CD8+ T cell therapy effectiveness in cancer.

This research investigates the role of tumor-specific CD4(+) T cells in improving CD8(+) T cell adoptive immunotherapy effectiveness.
Utilized a model with CD4(+) and CD8(+) T cells administered together and separately.
Assessed therapeutic efficacy by measuring effector and memory CD8(+) T cell numbers and cytokine expression.
Monitored effects of CD4(+) T cell elimination on CD8(+) T cell function.
Combined transfer of CD4(+) and CD8(+) T cells led to significant therapeutic efficacy (p ≤ 0.001).
Early elimination of CD4(+) T cells reduced therapeutic efficacy by over 50% (p < 0.001).
CD8(+) T cells from combined treatment exhibited reduced PD-1 expression, indicating lower exhaustion levels.

Church et al. (2013) studied this question.

View Full Paper

Ask AI

Bookmark